TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today announced that management will participate in the following investor conferences in September. 2026 Cantor Global Healthcare ConferenceDate: Wednesday, September 9,…
Real estate tech startup investors are being more selective about their bets and putting more money into companies using AI and other technology to make construction, property operations and real…
Mumbai: The Indian rupee strengthened by 28 paise to close at a nearly two-month high of 94.94 (provisional) against the US dollar on Tuesday, supported by robust domestic economic growth, controlled…
George Santos has been permanently suspended from Kalshi and ordered to pay $71,356 after the prediction market exchange concluded that… Continue reading Kalshi permanently suspends George Santos over…
Foreign portfolio investors poured $3.1 billion into Indian equities in August, the highest monthly inflow in nearly two years, aided by domestic companies’ strong earnings outlook and the central…
